Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin
Phase 1 Completed
99 enrolled 11 charts
Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma
Phase 1 Completed
8 enrolled
Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma
Phase 1 Completed
12 enrolled 13 charts
A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCL
Phase 1 Completed
111 enrolled
MNA-D
Phase 1 Completed
20 enrolled
CRAD001NUS175T
Phase 1 Completed
22 enrolled
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
Phase 1 Completed
150 enrolled 9 charts
Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Phase 1 Completed
46 enrolled 24 charts
A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer
Phase 1 Completed
165 enrolled
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung Cancer
Phase 1 Completed
22 enrolled
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast Cancer
Phase 1 Completed
9 enrolled 17 charts
Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery
Phase 1 Completed
16 enrolled
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia
Phase 1 Completed
24 enrolled
Combination Chemotherapy, Amifostine, and Peripheral Stem Cell Transplantation in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer
Phase 1 Completed
15 enrolled
Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
Phase 1 Completed
60 enrolled
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
Phase 1 Completed
83 enrolled
Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHL
Phase 1 Completed
6 enrolled
Study of CoQ10 During One Cycle of Doxorubicin Treatment for Breast Cancer
Phase 1 Completed
7 enrolled
PIPAC-OPC4
Phase 1 Completed
20 enrolled
V+DA-EPOCH-R
Phase 1 Completed
31 enrolled
A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis
Phase 1 Completed
15 enrolled
L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Phase 1 Completed
29 enrolled
Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma
Phase 1 Completed
10 enrolled
Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas
Phase 1 Completed
25 enrolled
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS
Phase 1 Completed
36 enrolled
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma
Phase 1 Completed
24 enrolled
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas
Phase 1 Completed
15 enrolled 18 charts
Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma
Phase 1 Completed
18 enrolled
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma
Phase 1 Completed
72 enrolled
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)
Phase 1 Completed
104 enrolled 9 charts
A Study of Olaratumab in Japanese Participants With Advanced Cancer
Phase 1 Completed
25 enrolled 19 charts
Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma or Grade 3b Follicular Lymphoma
Phase 1 Completed
30 enrolled 9 charts
KEYNOTE 173
Phase 1 Completed
60 enrolled 26 charts
A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Phase 1 Completed
24 enrolled 21 charts
Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Phase 1 Completed
7 enrolled
A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
Phase 1 Completed
68 enrolled 26 charts
Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors
Phase 1 Completed
122 enrolled 19 charts
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer
Phase 1 Completed
98 enrolled
Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)
Phase 1 Completed
23 enrolled
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
Phase 1 Completed
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
A Study of Olaratumab and Doxorubicin in Participants With Advanced Soft Tissue Sarcoma
Phase 1 Completed
49 enrolled 17 charts
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
Phase 1 Completed
15 enrolled 20 charts
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Phase 1 Completed
26 enrolled
A Study of Olaratumab (LY3012207) in Participants With Soft Tissue Sarcoma
Phase 1 Completed
51 enrolled 22 charts
Clinical Trial of Chidamide Combined With CHOP in Peripheral T-cell Lymphoma Patients
Phase 1 Completed
30 enrolled
Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Phase 1 Completed
41 enrolled
EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Phase 1 Completed
16 enrolled
AVD-Rev
Phase 1 Completed
30 enrolled
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Phase 1 Completed
11 enrolled